WOONSOCKET, R.I., 2017-Mar-10 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today that CVS Pharmacy locations in four additional states will dispense the opioid overdose reversal drug naloxone to patients without an individual prescription. With the addition of CVS Pharmacy locations in Arizona , Georgia , Iowa and South Carolina , CVS Pharmacy…
WOONSOCKET, R.I., , 2016-Dec-19 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (December 14, 2016) that the opioid overdose-reversal medication naloxone is now available without a prescription at all CVS Pharmacy locations in Nevada. CVS Health has established a standing order with physicians in Nevada that allows CVS Pharmacy to expand access to…
WOONSOCKET, R.I., 2016-Oct-03 — /EPR Retail News/ — CVS Health (NYSE: CVS) today (September 29, 2016) announced it has expanded access to the opioid overdose-reversal drug naloxone in Alabama, Alaska, Illinois, Missouri and West Virginia, allowing CVS Pharmacy patients to access the medication without an individual prescription. In total, CVS Pharmacy patients in 36 states now…
WOONSOCKET, R.I., 2016-Sep-15 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (Sept. 14, 2016) that the opioid overdose-reversal medication naloxone is now available for patients without a prescription at all CVS Pharmacy locations in Washington. Under a collaborative agreement with a physician in the state, CVS pharmacists can exercise prescriptive authority to dispense…
WOONSOCKET, R.I., 2016-May-25 — /EPR Retail News/ — CVS Health (NYSE: CVS) today announced it will expand access to the opioid overdose-reversal drug naloxone in seven additional states this summer, contributing to a total of 30 states where the life-saving medication will be more accessible to CVS Pharmacy patients. CVS Health's naloxone program establishes a standing…